Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Cancer. 2015 Nov 30;122(5):712–721. doi: 10.1002/cncr.29801

Table 2.

Vascular thromboembolic events (VTE) by treatment group.

GCbBev
(n=51; 26%)
GCis
(n=55; 28%)
GCb
(n=92; 46%)
p-value1
Any VTE 13 (25.5) 8 (14.5) 22 (23.9) 0.300
Type of VTE2 0.111
  Arterial 1 (7.7) 0 (0.0) 7 (31.8)
  Venous 12 (92.3) 8 (100.0) 15 (68.2)
1

p-value from Fisher's exact test.

2

Among those who had a VTE (n=43).